Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C62H89N13O14P.CN.Co |
| Molecular Weight | 1354.3762 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 13 / 14 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[57Co+3].[C-]#N.C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)C2[N-]C1=C(C)C3=NC(=CC4=NC(=C(C)C5=N[C@]2(C)[C@@](C)(CC(N)=O)[C@@H]5CCC(N)=O)[C@@](C)(CC(N)=O)[C@@H]4CCC(N)=O)C(C)(C)[C@@H]3CCC(N)=O)OP([O-])(=O)O[C@@H]6[C@@H](CO)O[C@@H]([C@@H]6O)N7C=[NH]C8=CC(C)=C(C)C=C78
InChI
InChIKey=FDJOLVPMNUYSCM-LFHMENBZSA-L
InChI=1S/C62H90N13O14P.CN.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;1-2;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);;/q;-1;+3/p-2/t31-,34-,35-,36-,37+,41-,52-,53-,56?,57+,59-,60+,61+,62+;;/m1../s1/i;;1-2
| Molecular Formula | Co |
| Molecular Weight | 56.936296235 |
| Charge | 3 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C62H87N13O14P |
| Molecular Weight | 1269.4066 |
| Charge | -3 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 13 / 14 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | CHN |
| Molecular Weight | 27.0253 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Cyanocobalamin Co 57 is a manufactured form of radiolabeled vitamin B indicated as an adjunct in diagnosing intestinal cyanocobalamin malabsorption syndromes due to lack of intrinsic factor (IF) or other defects in intestinal absorption (e.g., blind loop syndrome and diverticulitis, celiac disease, Crohn's disease, lesions in the small intestine, severe pancreatitis, tropical sprue).
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:55:51 GMT 2025
by
admin
on
Mon Mar 31 17:55:51 GMT 2025
|
| Record UNII |
025P9I542Y
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000177914
Created by
admin on Mon Mar 31 17:55:51 GMT 2025 , Edited by admin on Mon Mar 31 17:55:51 GMT 2025
|
||
|
NCI_THESAURUS |
C2124
Created by
admin on Mon Mar 31 17:55:51 GMT 2025 , Edited by admin on Mon Mar 31 17:55:51 GMT 2025
|
||
|
NDF-RT |
N0000000205
Created by
admin on Mon Mar 31 17:55:51 GMT 2025 , Edited by admin on Mon Mar 31 17:55:51 GMT 2025
|
||
|
WHO-ATC |
V09XX01
Created by
admin on Mon Mar 31 17:55:51 GMT 2025 , Edited by admin on Mon Mar 31 17:55:51 GMT 2025
|
||
|
WHO-VATC |
QV09XX01
Created by
admin on Mon Mar 31 17:55:51 GMT 2025 , Edited by admin on Mon Mar 31 17:55:51 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m11483
Created by
admin on Mon Mar 31 17:55:51 GMT 2025 , Edited by admin on Mon Mar 31 17:55:51 GMT 2025
|
PRIMARY | Merck Index | ||
|
13115-03-2
Created by
admin on Mon Mar 31 17:55:51 GMT 2025 , Edited by admin on Mon Mar 31 17:55:51 GMT 2025
|
PRIMARY | |||
|
4847
Created by
admin on Mon Mar 31 17:55:51 GMT 2025 , Edited by admin on Mon Mar 31 17:55:51 GMT 2025
|
PRIMARY | |||
|
SUB06838MIG
Created by
admin on Mon Mar 31 17:55:51 GMT 2025 , Edited by admin on Mon Mar 31 17:55:51 GMT 2025
|
PRIMARY | |||
|
Cyanocobalamin Co 57
Created by
admin on Mon Mar 31 17:55:51 GMT 2025 , Edited by admin on Mon Mar 31 17:55:51 GMT 2025
|
PRIMARY | |||
|
DB09385
Created by
admin on Mon Mar 31 17:55:51 GMT 2025 , Edited by admin on Mon Mar 31 17:55:51 GMT 2025
|
PRIMARY | |||
|
91516
Created by
admin on Mon Mar 31 17:55:51 GMT 2025 , Edited by admin on Mon Mar 31 17:55:51 GMT 2025
|
PRIMARY | RxNorm | ||
|
DTXSID901027626
Created by
admin on Mon Mar 31 17:55:51 GMT 2025 , Edited by admin on Mon Mar 31 17:55:51 GMT 2025
|
PRIMARY | |||
|
C76047
Created by
admin on Mon Mar 31 17:55:51 GMT 2025 , Edited by admin on Mon Mar 31 17:55:51 GMT 2025
|
PRIMARY | |||
|
100000093020
Created by
admin on Mon Mar 31 17:55:51 GMT 2025 , Edited by admin on Mon Mar 31 17:55:51 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110563
Created by
admin on Mon Mar 31 17:55:51 GMT 2025 , Edited by admin on Mon Mar 31 17:55:51 GMT 2025
|
PRIMARY | |||
|
025P9I542Y
Created by
admin on Mon Mar 31 17:55:51 GMT 2025 , Edited by admin on Mon Mar 31 17:55:51 GMT 2025
|
PRIMARY | |||
|
2802
Created by
admin on Mon Mar 31 17:55:51 GMT 2025 , Edited by admin on Mon Mar 31 17:55:51 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |